Journal Guide

Biotechnology Journal is the new, international resource for both biotechnology researchers and professionals in related disciplines. Fully comprehensive in its scope, the journal publishes strictly peer-reviewed papers covering novel aspects and methods in all areas of biotechnology. Special attention is also paid to the public, legal, ethical and cultural aspects of biotechnological research in the Forum section. Most issues are devoted to a special topic, providing the latest comprehensive information on the most crucial areas of research and technological advances. Alongside each highlighted topic, the journal contains original papers in the form of research articles, short communications and technical reports, illustrating the latest research results. BTJ welcomes submission of papers in areas including DNA/protein engineering, all -omics fields (genomics, proteomics, metabolomics, systems biology etc.), bioinformatics (algorithms and modeling), imaging, analytical biotech (sensors/detectors for analytes/macromolecules), plant/agricultural, food or environmental biotechnology, health and therapeutical biotechnology (including antisense/siRNAs, enzymes, peptides ...), regenerative medicine (stem cells, tissue engineering and biomaterials), translational immunology (antibody engineering, xenotransplantation, T-cell therapies), and biosafety or biosecurity. BTJ promotes a special emphasis on:

Biotechnology and Applied Biochemistry has been published continuously since its creation in 1986 (previous to that date it was called the Journal of Applied Biochemistry and was published from 1979 to 1985). Today it enjoys a superb track record, attracting distinguished authors from academia and industry from all over the world, reflecting its international status. Biotechnology and Applied Biochemistry is now published bi-monthly by Wiley-Blackwell, confirming the journal's dedication to change and commitment to rapid publication of high-quality, cutting-edge research at the interface between life sciences and their translation. It publishes new concepts in technology/methodology of relevance to the biological, biomedical, agricultural and environmental sciences. Promising advances in life sciences are leading to the identification of the molecular sources of disease and the creation of new generation of medicines for diseases for which there are currently either no therapies or inadequate treatments. Therapeutic proteins and antibodies are already having a significant impact in treatment of disease. Therapeutic genes and viruses promise to have an even bigger impact on human healthcare. DNA vaccine and gene-therapy are under intense development and new research areas such as tissue engineering, stem-cell therapeutics, germ-line therapy and regenerative medicines are expected to create a new wave of medicines that will make today's treatment of diseases look distinctively primitive. All this provides major challenges to life scientists and engineers engaged in discoveries and their translation to practical outcomes. Turning a new discovery into a successful application has become a highly integrated, multidisciplinary activity, and Biotechnology and Applied Biochemistry is uniquely placed to provide an international forum for the dissemination of information and discussion by researchers working across the many subject groups. The journal welcomes submissions of original articles on the following topics: nucleic acids and proteins engineering and purification; genes peptides and proteins therapy; biomaterials; biological modeling; stem cells and tissue engineering; bio-imaging; bio-sensors; biotechnology of food and natural compounds. Original papers and reviews as well as special issues can be also invited by the Editorial Board. Papers are easily submitted online at: http://mc.manuscriptcentral.com/bab.

Blood Cells, Molecules & Diseases emphasizes not only blood cells, but also covers the molecular basis of hematologic disease and studies of the diseases themselves. This is an invaluable resource to all those interested in the study of hematology, cell biology, immunology, and human genetics.Research Areas include:• Hematolymphopoiesis• Genetics of Blood Cells and Proteins• Molecular Biology of Blood Cells and Proteins• Pathophysiology of Blood Cells and Proteins• Hematological Malignancies• Disorders of Blood Cells and Coagulation ProteinsNote to Authors - please use the "Submit your paper" button on the right when submittingBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cancer, the second leading cause of death, is a heterogenous group of over 100 diseases. Cancer is characterized by disordered and deregulated cellular and stromal proliferation accompanied by reduced cell death with the ability to survive under stresses of nutrient and growth factor deprivation, hypoxia, and loss of cell-to-cell contacts. At the molecular level, cancer is a genetic disease that develops due to the accumulation of mutations over time in somatic cells. The phenotype includes genomic instability and chromosomal aneuploidy that allows for acceleration of genetic change. Malignant transformation and tumor progression of any cell requires immortalization, loss of checkpoint control, deregulation of growth, and survival. A tremendous amount has been learned about the numerous cellular and molecular genetic changes and the host-tumor interactions that accompany tumor development and progression. It is the goal of the field of Molecular Oncology to use this knowledge to understand cancer pathogenesis and drug action, as well as to develop more effective diagnostic and therapeutic strategies for cancer. This includes preventative strategies as well as approaches to treat metastases. With the availability of the human genome sequence and genomic and proteomic approaches, a wealth of tools and resources are generating even more information. The challenge will be to make biological sense out of the information, to develop appropriate models and hypotheses and to translate information for the clinicians and the benefit of their patients. Cancer Biology & Therapy aims to publish original research on the molecular basis of cancer, including articles with translational relevance to diagnosis or therapy. We will include timely reviews covering the broad scope of the journal. The journal will also publish op-ed pieces and meeting reports of interest. The goal is to foster communication and rapid exchange of information through timely publication of important results using traditional as well as electronic formats. The journal and the outstanding Editorial Board will strive to maintain the highest standards for excellence in all activities to generate a valuable resource.

Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; preliminary communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of timely in-depth, reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

For more information, go to http://www.cell.com/cell-stem-cell/home

Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology will form a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologist and other clinicians involved in the managemen

Based in Basel, Switzerland, the multidisciplinary journal Cellular and Molecular Life Sciences (CMLS) publishes research articles, reviews, multi-author reviews and visions & reflections articles covering the latest aspects of biological and biomedical research. The journal will consider contributions focusing on biochemistry and molecular biology, cell biology, molecular and cellular aspects of biomedicine, neuroscience, pharmacology and immunology. In addition, CMLS welcomes comments on any article published in CMLS. Publication Schedule
One volume comprising 24 issues per year Peer Review
Of all contributions by an international board of experts Short Publication Time
Decision on acceptance/rejection within 1 month (for research articles) Online First publication; publication of the print version no more than 2 months after acceptance (for research articles) Illustrations
Black & white, color illustrations at no cost Page Charges
None

Reprints
30 complimentary reprints

Central Nervous System Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of new central nervous system agents.

ChemBioChem is an international forum for short communications, full papers, reviews & minireviews and highlights & concepts. ChemBioChem (Impact Factor 2009: 3.824) is a source for important primary and secondary information across the whole field of chemical biology, bio(in)organic chemistry, and biochemistry. Its mission is to integrate this wide and flourishing field, ranging from complex carbohydrates through peptides/proteins to DNA/RNA, from combinatorial chemistry and biology to signal transduction, from catalytic antibodies to protein folding, from bioinformatics and structural biology to drug design - to name just a few topics.

Aims and Scope Download Flyer With an impact factor of 3.232 (2009).ChemMedChemon its way to become a premier journal at the interface of chemistry. biology and medicine.ChemMedChemis made in Europe. but publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences. ranging from drug design and discovery to drug development and delivery. from molecular modeling to combinatorial chemistry. from target validation to lead generation and ADMET studies—to name just a few topics. Contents ChemMedChempublishes an attractive mixture of: Short Communications and Full PapersMinireviews and ReviewsHighlights and ConceptsBook and Multimedia ReviewsFields of Interest ChemMedChemtears down the walls between chemistry. biology. and medicine: drug design and discoverydrug development and deliverytarget validationlead generationADMET studiesscreeningbiological activity studiescombinatorial techniquesmolecular modelingsynthesis of biologically active compoundsmetabolism in drug actionsmolecular recognition at receptorsinteraction of ligands and receptorsapplications of NMR and X-ray crystallography ChemMedChemis accepted for coverage in MEDLINE. ISSN: 1860-7179 (print). 1860-7187 (online). CODEN: CHEMGX. Volume 6. 12 Issues in 2011. Masthead Masthead(PDF) –[Show history][Hide history] How to cite:To make sure that references to this journal are correctly recorded and resolved (for example in CrossRef or ISI Web of Science). please use the following abbreviated title in any citations: 'ChemMedChem' (punctuation may vary according to the style of the citing journal).

Chemical Biology & Drug Design is a peer-reviewed scientific journal that is dedicated to the advancement of innovative science, technology and medicine with a focus on the multidisciplinary fields of chemical biology and drug design. It is the aim of Chemical Biology & Drug Design to capture significant research and drug discovery that highlights new concepts, insight and new findings within the scope of chemical biology and drug design. The following scientific topics will exemplify the scope of the journal:.

Aims and Scope Download Flyer The journal aims to elucidate the overlap between the chemical and biological sciences. CHEMISTRY and BIODIVERSITY demonstrates how chemistry can contribute to our understanding of biodiversity with the ultimate goal of benefiting from our preserving nature. Chemistry and Biodiversitypublishes articles on all aspects of biodiversity studied at the molecular and macromolecular levels. Papers include full-length original research articles. short communications. invited reviews. and commentaries. The Impact Factor is 1.926 (2009 Journal Citation Reports. Thomson Reuters. 2010) and the journal is indexed in Pubmed/MEDLINE. CHEMISTRY and BIODIVERSITY is the official journal of the Center for the Study of Biological Complexity (CSBC). Virginia Commonwealth University. USA If you would like to receive an e-mail as soon as a new issue has been published. simply click on 'Set E-Mail Alert' above. Registration is easy. fast and free. ISSN: 1612-1872 (print). 1612-1880 (online). Volume 8. 12 Issues in 2011. How to cite:To make sure that references to this journal are correctly recorded and resolved (for example in CrossRef or ISI Web of Science). please use the following abbreviated title in any citations: 'Chem. Biodiv.' (punctuation may vary according to the style of the citing journal). Readership All chemists and chemically interested scientists from life-science community Keywords Biocatalysis.

Every paper has its own priorities. Be it rapid publication, strong circulation, society affiliation or the prestige of a high Impact Factor, we help pharmaceutical companies, medcomms agencies and medical writers identify the Informa Healthcare journal that will help them achieve their publication objectives.We actively encourage pre-submission discussions with our team and Informa Healthcare editors to ensure your submission process is as efficient and effective as possible. You are welcome to contact us directly to discuss your upcoming manuscripts. Alternately, if you would like to browse our portfolio of 168 journals, you can do so using the tool below.

CrystEngComm is the forum for the design and understanding of crystalline materials. It publishes studies on the investigation of molecular behaviour within crystals, control of nucleation and crystal growth, engineering of crystal structures, and construction of crystalline materials with tuneable properties and functions. All papers should involve the use or development of a design or optimisation strategy.

Current Cancer Therapy Reviews publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.